Expert's Opinion

The Real Cost of Bringing Manufacturing Home

Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.

08.04.21

Biologics, Proteins, Vaccines | Drug Development

AAV-Mediated Gene Therapy: Quantifying Viral Titer and Integrity

Droplet Digital PCR offers precise potency data, critical for the proper dosing of gene therapies.

Mark White and Marwan Alsarraj , Digital Biology Group at Bio-Rad 07.27.21

Laboratory Testing

Overcoming the Customization Conundrum

A case study on automating diagnostic reagent filling.

Deborah Smook, VP of Marketing & Business Development, TurboFil Packaging Machines LLC 07.12.21

Nanotechnology & Medtech: A New Frontier

Three reasons why U.S. medtech companies go overseas for nanotechnology research.

Rachel Shelly, Head of Medical Technologies, IDA Ireland 07.09.21

Biologics, Proteins, Vaccines | cGMP Manufacture

Can mRNA Facilities Really be Flexible?

Four key questions to accommodate growth and expansion.

Jeff Heil, PE , Novel Therapy SME, DPS Group Global 07.08.21

Clinical Trials | Information Technology

The Power and Promise of Decentralized Trials

Clinical researchers turned to a range of digital solutions to address the effects of the COVID-19 pandemic on trials.

Derk Arts, CEO, Castor 06.25.21

Clinical Trials | Drug Development

The Future is Decentralized: What This Means for Clinical Trial Sites

Benefits for research sites and how to prepare for decentralized trials.

Marc Leighton, Vice President of Product at Florence Healthcare 06.02.21

Bioanalytical Services | Biologics, Proteins, Vaccines

The Future of Continuous Bioprocessing

The Modernization of Advanced Therapy Manufacturing

Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 05.27.21

Biologics, Proteins, Vaccines | Clinical Trials | Drug Development

Gene Therapy Trials

Critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.

April Marquick, Cell and Gene Therapy Expert, Premier Research 05.26.21

APIs | Cytotoxics and High Potency Manufacturing | Formulation Development | Process Development

Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion

Efficient processing and production technology for solid molecular dispersion, HME can provide sustained, modified and targeted drug delivery.

Ameya Deshpande, Formulation Scientist, Avomeen 05.25.21

Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids

PharmParts – This Makes Sense!

5 reasons to consider purchasing secondhand parts.

Justin Kadis, Business Development, Federal Equipment 04.06.21

Cold Chain Management

Cold-Chain Handling Is Not Just a COVID Vaccine Challenge

More robust solutions for single-use cold-chain containers made with polytetrafluoroethylene fluoropolymers may be less susceptible to failure and breakage.

Joe Cintavey, Gore PharmBIO 03.30.21

cGMP Manufacture | Drug Development | Scale-up/Technology Transfer

Fast Track Automation in Pharmaceutical Manufacturing

Drug manufacturers turn to advanced automation technologies and project execution methodologies to reduce time, cost and risk

Steve Zarichniak, Technical Solutions Consultant, Honeywell Process Solutions 03.25.21

Clinical Trials | Drug Development

Regulatory Practices in a Post-Pandemic World

Envisioning the new normal for clinical development.

Dr. Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA 03.22.21

Clinical Trials | Information Technology

The Evolution of Clinical Research Technology to Support Remote Collaboration

Pioneering change with technology advancements that yield high reward with tolerable risk.

Angela Gill Nelms, COO for Florence Healthcare 03.11.21

cGMP Manufacture | Process Development | Scale-up/Technology Transfer

Process Intensification: Understanding the Optimal Way to Maximize Productivity

Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.

Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21

Clinical Trials | Information Technology